Fig. 2
From: Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients
Whole blood miRNA levels inter-differentiating the same patient group at T0 and T1. The dot plots show relative levels of the different oncogenic miR-19a, − 21 and − 22 (a) and tumor suppressor miR-20a, − 127 and -200b (b). The differences were calculated using the Wilcoxon test; only the corresponding significant p-values are indicated in the graphs (*p ≤ 0.05). (T0: before adjuvant therapy; T1: after adjuvant therapy)